HOME >> BIOLOGY >> NEWS
Autoimmune Diseases Study Shows Differences Between Men And Women

COLUMBUS, Ohio -- A national task force of basic researchers and clinicians spent 18 months assessing what is known about autoimmune diseases and has now proposed an aggressive research agenda aimed at understanding why men and women respond differently to these illnesses

Their report, published in this week's issue of the journal Science, recommends five distinct research areas which may explain these differences and perhaps, even offer new treatments against the diseases. A longer companion report is available at Science's website.

The human immune system normally swings into action to fight an invading bacteria, virus or toxin. But in autoimmune diseases, the body's immune system begins to attack normal, healthy tissue instead. Rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis are all important autoimmune diseases that affect men and women differently.

But just what causes these differences in symptoms, disease severity, incidence, remission and other factors isn't clear. Nearly 79 percent of the 8.5 million autoimmune disease patients in the country are women. Twice to three times as many women get multiple sclerosis and rheumatoid arthritis each year, compared to men, and for systemic lupus erythematosus, women outnumber men nine to one.

"One of the big problems we faced was that very few people do studies that are specifically directed at differences between the sexes regarding these diseases," explained Caroline Whitacre, professor of medical microbiology and immunology at Ohio State University and chair of the task force. "Often in papers dealing with immunology, you can't tell the sex of the patients, based on reading the article."

The group of 15 scientists, convened Patricia O'Looney and Stephen Reingold of the National Multiple Sclerosis Society, first reviewed more than 75 different papers in the scientific literature. From that and numerous discussion
'"/>

Contact: Caroline Whitacre
Whitacre.3@osu.edu
614-292-5889
Ohio State University
26-Feb-1999


Page: 1 2 3

Related biology news :

1. Autoimmune Diseases May Be Triggered By Cells From Your Mother
2. Duke Researchers Discover Candidate Susceptibility Gene For Autoimmune Disease
3. APS Inflammatory Bowel Diseases Translational Research Conference, Sept. 8-11
4. International Conference on Emerging Infectious Diseases
5. NIH establishes Rare Diseases Clinical Research Network
6. 2002 International Conference on Emerging Infectious Diseases
7. New Gene Holds Promise For Controlling Crohns And Other Inflammatory Diseases
8. HHMI To Award $14 Million In New International Program To Support Research On Infectious And Parasitic Diseases
9. Sandia Discovery About Protein May Help Clean Up Pollutants, Find Cures For Diseases
10. Researcher Awarded Patent For System To Fight Multiple Diseases
11. Genetic Research Boosts Understanding Of Irons Path Through Body, Diseases Of Iron Metabolism

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Autoimmune Diseases Study Shows Differences Between Men And Women

(Date:8/12/2015)... , Aug. 12, 2015   MedNet Solutions ... the entire spectrum of clinical research, is proud to ... the company,s comprehensive SaaS-based eClinical technology platform, has led ... the first two quarters of 2015.   Q2 2015 ... largest quarters measured by contract value sold in the ...
(Date:8/12/2015)... Aug. 12, 2015  New research unveiled at ... Android phones to steal users, fingerprints. Information released ... of fingerprint scanners on mobile devices, making the ... secure biometrics on mobile devices, HYPR Corp. recently ... convenient authentication systems with strong cryptographic security. More ...
(Date:8/11/2015)... -- Today, ZUK announced its Android smartphone Z1, featuring ... revenues in 2015 that relate to sales of FPC1155 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... smartphone manufacturer in China and we ... 155 for Z1 , ...
Breaking Biology News(10 mins):MedNet Solutions Experiences Explosive Corporate Growth 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 2HYPR Corp. Addresses Android Vulnerability That Exposes Ecosystem-wide Biometric Security Challenges 3FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
(Date:8/27/2015)... GlassesOff (OTCBB: GLSO), a visual neuroscience technology company ... system, announced today a partnership with eight-time All-Star, ... to develop a new mobile app designed for professional and ... performance. Vision is the inception of every move ... or blocking a pass. The critical impact vision speed has ...
(Date:8/26/2015)... ... August 26, 2015 , ... MediVet Biologics, a leader in ... is to open in Manhattan, Kansas in early October, 2015. The location of ... research and development through collaboration with researchers from Kansas State University’s College of ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic company ... has received a $1.5M Phase II SBIR grant ... further develop its therapeutic agent to reduce arteriovenous ... in end stage renal disease (ESRD) patients undergoing ... Institute of Diabetes and Digestive and Kidney Diseases ...
(Date:8/26/2015)... 26, 2015 Despite recent ... the optimism in biotech,s forecast is the recent ... sciences advancements.  Active biotechnology & healthcare companies with ... (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: SQNM ), ... Pharmaceutical Corp. (NASDAQ: RPTP ) and EnteroMedics ...
Breaking Biology Technology:Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 2Eight-Time All-Star Chris Paul and GlassesOff Partner to Develop Innovative Mobile App Designed to Improve On-Court Performance 3MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 2MediVet Biologics Animal Health Secures Additional Laboratory Facility in Manhattan, Kansas 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
Cached News: